-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Financial App News, Boan Biotech (06955.HK) announced that the company's marketing license application for abacip intraocular injection solution (BA9101) has been submitted to Brazil's National Health Administration (ANVISA) to treat neovascularization (wet) age-related macular degeneration (NaMD) and diabetic macular edema (DME) in adults.

Zhitongcaijing·08/05/2026 12:09:09
Listen to the news
Zhitong Financial App News, Boan Biotech (06955.HK) announced that the company's marketing license application for abacip intraocular injection solution (BA9101) has been submitted to Brazil's National Health Administration (ANVISA) to treat neovascularization (wet) age-related macular degeneration (NaMD) and diabetic macular edema (DME) in adults.